Morningstar Global Brain Health Innovation Index: Neurology Will Likely Be The Focus Of Next Wave Of Pharmaceutical Innovation
The oncoming wave of innovation has the potential to significantly help patients across a broad range of neurological disorders while rewarding investors supporting the companies that are leading in neurological research and development. Key findings at a snapshot The effects of the aging U.S. (and global) population. With direct medical costs expected to balloon, new therapies that can treat strokes and conditions like Alzheimer’s are needed with improved safety, efficacy, and flexibility.The next wave of pharmaceutical innovation will likely center on neurology. Innovation in healthcare tend...